Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL single dose vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

epirubicin hydrochloride, Quantity: 2 mg/mL

Disponible depuis:

Hospira Australia Pty Ltd

DCI (Dénomination commune internationale):

epirubicin hydrochloride

forme pharmaceutique:

Injection, solution

Composition:

Excipient Ingredients: sodium chloride; water for injections

Mode d'administration:

Intravenous Infusion

Unités en paquet:

5 vials per pack

classe:

Medicine Listed (Export Only)

Type d'ordonnance:

(S1) This Schedule is intentionally blank

indications thérapeutiques:

1. Relief of subjective and objective symptoms in the following diseases: Acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. Treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: Breast cancer (pre- and post-operative chemotherapy in operable cases)

Descriptif du produit:

Visual Identification: Epirubicin Hydrochloride Injection is a clear red solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2013-05-08